Browse > Article
http://dx.doi.org/10.7783/KJMCS.2016.24.1.7

Effects of 6-Shogaol, A Major Component of Zingiber officinale Roscoe, on Human Cytochrome P450 Enzymes in vitro  

Kim, Jin (Department of Nursing, Gwangju Health University)
Publication Information
Korean Journal of Medicinal Crop Science / v.24, no.1, 2016 , pp. 7-13 More about this Journal
Abstract
Background : Ginger has been extensively used in foods and traditional medicines in Asian countries. Despite its frequent consumption in daily life, the mechanism of potential interactions between ginger components-drug has not been examined. To elucidate the mechanism of governing the effects of 6-shogaol, a primary constituent of dried ginger, on human cytochrome P450 (CYP) isoenzymes an incubation studies were carried out using pooled human liver microsome (HLM). Methods and Results : CYP isoenzyme specific substrate was incubated with multiple concentrations of inhibitor, HLM and cofactors. 6-shogaol showed a potent inhibitory effect on CYP2C9, CYP1A2 and CYP2C19 with half maximal inhibitory concentration ($IC_{50}$) values of 29.20, 20.68 and $18.78{\mu}M$ respectively. To estimate the value of the inhibition constant ($K_i$) and the mode of inhibition, an incubation study with varying concentrations of each CYP isoenzyme-specific probe was performed. 6-shogaol inhibited CYP2C9 and CYP2C19 noncompetitively ($K_i=29.02$ and $19.26{\mu}M$ respectively), in contrast, the inhibition of CYP1A2 was best explained by competitive inhibition ($K_i=6.33{\mu}M$). Conclusions : These findings suggest that 6-shogaol may possess inhibitory effects on metabolic activities mediated by CYP1A2, CYP2C9 and CYP2C19 in humans.
Keywords
Zingiber officinale; Cytochrome P450; Inhibition Constant; 6-Shogaol;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Baliga MS, Haniadka R, Pereira MM, D'Souza JJ, Pallaty PL, Bhat HP and Popuri S. (2011). Update on the chemopreventive effects of ginger and its phytochemicals. Critical Reviews in Food Science and Nutrition. 51:499-523.   DOI
2 Cameron MD, Wen B, Allen KE, Roberts AG, Schuman JT, Campbell AP, Kunze KL and Nelson SD. (2005). Cooperative binding of midazolam with testosterone and ${\alpha}$-naphthoflavone within the CYP3A4 active site: A NMR $T_1$ paramagnetic relaxation study. Biochemistry. 44:14143-14151.   DOI
3 Court MH, Von Moltke LL, Shader RI and Greenblatt DJ. (1997). Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species. Biopharmaceutics and Drug Disposition. 18:213-226.   DOI
4 Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S and Korlakunta JN. (2010). Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol, and [6]-shogaol. Journal of Ethnopharmacology. 127:515-520.   DOI
5 Ernst E and Pittler MH. (2000). Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials. British Journal of Anaesthesia. 84:367-371.   DOI
6 Izzo AA and Ernst E. (2009). Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs. 69:1777-1798.   DOI
7 Joo SY and Lim YC. (2011). Inhibitory effects of 6-gingerol on cytochrome P450 in human liver microsomes. The Journal of Korean Society for Clinical Pharmacology and Therapeutics. 19:52-58.
8 Kim JS, Lee SI, Park HW, Yang JH, Shin TY, Kim YC, Baek NI, Kim SH, Choi SU, Kwon BM, Leem KH, Jung MY and Kim DK. (2008). Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe. Archives of Pharmacal Research. 31:415-418.   DOI
9 Pelkonen O and Breimer DD. (1994). Role of environmental factors in the pharmacokinetics of drugs: Considerations with respect to animal models, P-450 enzymes, and probe drugs. In Peter GW and Luc PB(ed.). Handbook of Experimental Pharmacology. Springer. New York. NY, USA. p.289-332.
10 Relling MV, Aoyama T, Gonzalez FJ and Meyer UA. (1990). Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. Journal of Pharmacology and Experimental Therapeutics. 252:442-447.
11 Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J and Liu JR. (2007). Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complementary and Alternative Medicine. 7:44.   DOI
12 Shim S, Kim S, Choi DS, Kwon YB and Kwon J. (2011). Antiinflammatory effects of [6]-shogaol: Potential roles of HDAC inhibition and HSP70 induction. Food and Chemical Toxicology. 49:2734-2740.   DOI
13 Tassaneeyakul W, Birkett DJ, Veronese ME, Mcmanus ME, Turkey RH, Quattrochi LC, Gelboin HV and Miners JO. (1993). Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Journal of Pharmacology and Experimental Therapeutics. 265:401-407.
14 Shim S, Kim S, Kwon YB and Kwon J. (2012). Protection by [6]-shogaol against lipopolysaccharide-induced toxicity in murine astrocytes is related to production of brain-derived neurotrophic factor. Food and Chemical Toxicology. 50:597-602.   DOI
15 Shukla Y and Singh M. (2007). Cancer preventive properties of ginger: A brief review. Food and Chemical Toxicology. 45:683-690.   DOI
16 Tang W and Stearns RA. (2001). Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions. Current Drug Metabolism. 2:185-198.   DOI
17 Tsai TH, Tsai PJ and Ho SC. (2005). Antioxidant and antiinflammatory activities of several commonly used spices. Journal of Food Science. 70:C93-C97.   DOI
18 Wang YH, Jones DR and Hall SD. (2005). Differential mechanismbased inhibition of CYP3A4 and CYP3A5 by verapamil. Drug Metabolism and Disposition. 33:664-671.   DOI
19 Wrighton SA, Stevens JC, Becker GW and Vandenbraden M. (1993). Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4'-hydroxylation. Archives of Biochemistry and Biophysics. 306:240-245.   DOI
20 Yu Y, Zick S, Li X, Zou P, Wright B and Sun D. (2011). Examination of the pharmacokinetics of active ingredients of ginger in humans. AAPS Journal. 13:417-426.   DOI
21 Zhang W and Lim LY. (2008). Effects of spice constituents on P-glycoproteinmediated transport and CYP3A4-mediated metabolism in vitro. Drug Metabolism and Disposition. 36:1283-1290.   DOI